• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Egyptian Journal of Histology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 43 (2020)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 42 (2019)
Volume Volume 41 (2018)
Volume Volume 40 (2017)
kelada, M., Metwaly, .., Safwat, M., Abd El Mottelib, L. (2020). Assessment of the Potential Genotoxicity and Cardiac Teratogenicity of Venlafaxine on Embryos of Pregnant Black Mice. Egyptian Journal of Histology, 43(3), 732-747. doi: 10.21608/ejh.2019.15379.1150
melad naim kelada; .El Sayed Ali Metwaly; Maha Diaa ELl deen Safwat; Lobna Mohammed Abd El Mottelib. "Assessment of the Potential Genotoxicity and Cardiac Teratogenicity of Venlafaxine on Embryos of Pregnant Black Mice". Egyptian Journal of Histology, 43, 3, 2020, 732-747. doi: 10.21608/ejh.2019.15379.1150
kelada, M., Metwaly, .., Safwat, M., Abd El Mottelib, L. (2020). 'Assessment of the Potential Genotoxicity and Cardiac Teratogenicity of Venlafaxine on Embryos of Pregnant Black Mice', Egyptian Journal of Histology, 43(3), pp. 732-747. doi: 10.21608/ejh.2019.15379.1150
kelada, M., Metwaly, .., Safwat, M., Abd El Mottelib, L. Assessment of the Potential Genotoxicity and Cardiac Teratogenicity of Venlafaxine on Embryos of Pregnant Black Mice. Egyptian Journal of Histology, 2020; 43(3): 732-747. doi: 10.21608/ejh.2019.15379.1150

Assessment of the Potential Genotoxicity and Cardiac Teratogenicity of Venlafaxine on Embryos of Pregnant Black Mice

Article 5, Volume 43, Issue 3, September 2020, Page 732-747  XML PDF (1.85 MB)
Document Type: Original Article
DOI: 10.21608/ejh.2019.15379.1150
Authors
melad naim kelada email 1; .El Sayed Ali Metwalyorcid 2; Maha Diaa ELl deen Safwat3; Lobna Mohammed Abd El Mottelib4
1anatomy department, faculty of medicine , Alexandria university
2Human Anatomy and Embryology,Faculty of Medicine, Alexandria University, Alexandria, Egypt.
3anatomy department,faculty of medicine, Alexandria university, Alexandria, Egypt
4anatomy and embryology department, faculty of medicine, Alexandria university, Alexandria, Egypt
Abstract
Background: Depression during pregnancy is a very common problem worldwide, so the possibility of intake antidepressant medications during pregnancy is high. In Egypt, about 60% of pregnant women experience someforms of antenatal depression.
The most widely prescribed antidepressants worldwide are Selective serotonin and serotonin–norepinephrine reuptake inhibitors (SSRIs and SNRIs).The mechanism of action is poorly understood but in general, these drugs act by blocking the serotonin and/or norepinephrine transporters.
Aim: The aim of this study is to investigate the effect of venlafaxine- one of the most widely prescribed SSRI (Selective serotonin reuptake inhibitors) on DNA, and also study its possible teratogenic effect on cardiac development.
Methods: The present study was carried out on fifty pregnant black mice (C57BL/6).The mice were randomly assigned to one of two groups: a control and venlafaxine-treated groups receiving (3mg, 10mg, 30mg and 100mg/kg/day). The fetuses were dissected for the evaluation of their cardiac structure. The micronucleus test was used to detect the ability of venlafaxine to induce DNA damage.
Results: The present work showed that administration of increasing concentrations of venlafaxine resulted in significant increase in the incidence of embryo heart anomalies in black mice as VSD, pulmonary trunk dilatation and right ventricle enlargement as compared to the control group. Also, this study showed an increase in the frequency of micronuclei in the blood of the adult mice after exposure to increasing dose of venlafaxine.
Conclusions: Physicians should make a proper decision regarding prescription of SSRI in general and venlafaxine, in particular, to treat depression during pregnancy weighing the risks and benefits for both mother and fetus.
Keywords
Cardiac anomalies; genotoxicity; micronucleus; pregnancy depression; venlafaxine
Statistics
Article View: 244
PDF Download: 26
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.